Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

New Brunswick, New Jersey 08903


Purpose:

Purpose of the study is to evaluate the effectiveness and safety of a new investigational dur, IC351. Study is designed to gather information regarding the possible usefulness of IC351 as a treatment of several blood vessel features of scleroderma. This includes Raynaud phenomenon as well as the vaginal dryness and discomfort associated with scleroderma


Criteria:

Inclusion Criteria: - Female with diagnosis of scleroderma - Stable sexual relationship with male partner or be sexually active - Raynaud phenomenon at least 6 times per week - Willing to attempt sexual activity 1/month during study period Exclusion Criteria: - Severe internal organ problems related to scleroderma - Other gynecologic problems - Serious depression - Receiving other experimental and Raynaud treatments


NCT ID:

NCT00707187


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

New Brunswick, New Jersey 08903
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.